Renesola ignores challenging market to launch follow-on

The US-listed solar power play is aiming to raise about $170 million. Meanwhile, UOB tries to sell a $38.6 million stake in WuXi PharmaTech at a fixed-price.

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition

CONFERENCES